An Indian Institute of Technology Madras Research has called for greater Government investment in public healthcare to mitigate the impact of COVID-19 on the elderly. The current pandemic poses a greater risk of social isolation...
The Prime Minister, Shri Narendra Modi addressed the nation today. The Prime Minister expressed condolences for the people who lost their lives in the pandemic. Terming the pandemic the biggest calamity of the last...
Overcoming all hurdles and finding new solutions, Indian Railways is continuing its journey of bringing relief by delivering Liquid Medical Oxygen(LMO) to various states across the country. Oxygen Expresses crossed the mark of 26000 MT...
COVID-19 is causing a major global pandemic. The scientific and clinical community are actively engaged to develop effective preventions and treatments. A key strategy to protect humans from this coronavirus pandemic is the development of...
Union Minister Dr. Jitendra Singh, who is also a former Professor of Diabetes and Medicine besides being the Life Patron of the coveted RSSDI (Research Society for Study of Diabetes in India), said today that...
Dr. Harsh Vardhan, Union Minister of Health & Family Welfare chaired the 28th meeting of the High-level Group of Ministers (GoM) on COVID-19 by a video conference, here today. He was joined by Dr. S....
The government of India has been supporting the efforts of States and UTs under the ‘Whole of Government” approach for ensuring a smooth and effective vaccination drive since 16th January this year. The Union Government...
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In addition, the Govt. of India has also been facilitating...
On the behalf of the Railway Employees, the General Secretary of Southern Railway Mazdoor Union, Dr. N. Kanniah, Phd., also the President of All Indian Railwaymen Federation and also the Joint Secretary of JCM (comprising...
CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment of Covid-19. The trial is a multi-centric, phase-II, randomized, open label clinical study to evaluate...
